559 related articles for article (PubMed ID: 30211160)
1. CD44/CD44v6 a Reliable Companion in Cancer-Initiating Cell Maintenance and Tumor Progression.
Wang Z; Zhao K; Hackert T; Zöller M
Front Cell Dev Biol; 2018; 6():97. PubMed ID: 30211160
[TBL] [Abstract][Full Text] [Related]
2. CD44v6-competent tumor exosomes promote motility, invasion and cancer-initiating cell marker expression in pancreatic and colorectal cancer cells.
Wang Z; von Au A; Schnölzer M; Hackert T; Zöller M
Oncotarget; 2016 Aug; 7(34):55409-55436. PubMed ID: 27419629
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic cancer-initiating cell exosome message transfer into noncancer-initiating cells: the importance of CD44v6 in reprogramming.
Wang Z; Sun H; Provaznik J; Hackert T; Zöller M
J Exp Clin Cancer Res; 2019 Mar; 38(1):132. PubMed ID: 30890157
[TBL] [Abstract][Full Text] [Related]
4. The Pancreatic Cancer-Initiating Cell Marker CD44v6 Affects Transcription, Translation, and Signaling: Consequences for Exosome Composition and Delivery.
Sun H; Rana S; Wang Z; Zhao K; Schnölzer M; Provaznik J; Hackert T; Lv Q; Zöller M
J Oncol; 2019; 2019():3516973. PubMed ID: 31485223
[TBL] [Abstract][Full Text] [Related]
5. CD44 and EpCAM: cancer-initiating cell markers.
Marhaba R; Klingbeil P; Nuebel T; Nazarenko I; Buechler MW; Zoeller M
Curr Mol Med; 2008 Dec; 8(8):784-804. PubMed ID: 19075676
[TBL] [Abstract][Full Text] [Related]
6. Claudin7-dependent exosome-promoted reprogramming of nonmetastasizing tumor cells.
Kyuno D; Zhao K; Schnölzer M; Provaznik J; Hackert T; Zöller M
Int J Cancer; 2019 Oct; 145(8):2182-2200. PubMed ID: 30945750
[TBL] [Abstract][Full Text] [Related]
7. Exosomes, metastases, and the miracle of cancer stem cell markers.
Wang Z; Zöller M
Cancer Metastasis Rev; 2019 Jun; 38(1-2):259-295. PubMed ID: 31030373
[TBL] [Abstract][Full Text] [Related]
8. CD44 variant 6 is correlated with peritoneal dissemination and poor prognosis in patients with advanced epithelial ovarian cancer.
Tjhay F; Motohara T; Tayama S; Narantuya D; Fujimoto K; Guo J; Sakaguchi I; Honda R; Tashiro H; Katabuchi H
Cancer Sci; 2015 Oct; 106(10):1421-8. PubMed ID: 26250934
[TBL] [Abstract][Full Text] [Related]
9. Ping-Pong-Tumor and Host in Pancreatic Cancer Progression.
Mu W; Wang Z; Zöller M
Front Oncol; 2019; 9():1359. PubMed ID: 31921628
[TBL] [Abstract][Full Text] [Related]
10. A complex of EpCAM, claudin-7, CD44 variant isoforms, and tetraspanins promotes colorectal cancer progression.
Kuhn S; Koch M; Nübel T; Ladwein M; Antolovic D; Klingbeil P; Hildebrand D; Moldenhauer G; Langbein L; Franke WW; Weitz J; Zöller M
Mol Cancer Res; 2007 Jun; 5(6):553-67. PubMed ID: 17579117
[TBL] [Abstract][Full Text] [Related]
11. CD44 variant 6 is associated with prostate cancer metastasis and chemo-/radioresistance.
Ni J; Cozzi PJ; Hao JL; Beretov J; Chang L; Duan W; Shigdar S; Delprado WJ; Graham PH; Bucci J; Kearsley JH; Li Y
Prostate; 2014 May; 74(6):602-17. PubMed ID: 24615685
[TBL] [Abstract][Full Text] [Related]
12. CD44 Variant 6 as a Predictive Biomarker for Distant Metastasis in Patients With Epithelial Ovarian Cancer.
Motohara T; Fujimoto K; Tayama S; Narantuya D; Sakaguchi I; Tashiro H; Katabuchi H
Obstet Gynecol; 2016 Jun; 127(6):1003-1011. PubMed ID: 27159753
[TBL] [Abstract][Full Text] [Related]
13. Tspan8, CD44v6 and alpha6beta4 are biomarkers of migrating pancreatic cancer-initiating cells.
Wang H; Rana S; Giese N; Büchler MW; Zöller M
Int J Cancer; 2013 Jul; 133(2):416-26. PubMed ID: 23338841
[TBL] [Abstract][Full Text] [Related]
14. Interplay Between Chemotherapy-Activated Cancer Associated Fibroblasts and Cancer Initiating Cells Expressing CD44v6 Promotes Colon Cancer Resistance.
Ghatak S; Hascall VC; Karamanos N; Markwald RR; Misra S
Front Oncol; 2022; 12():906415. PubMed ID: 35982950
[TBL] [Abstract][Full Text] [Related]
15. CD44 promotes progenitor homing into the thymus and T cell maturation.
Rajasagi M; Vitacolonna M; Benjak B; Marhaba R; Zöller M
J Leukoc Biol; 2009 Feb; 85(2):251-61. PubMed ID: 18955544
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic cancer stem cell markers and exosomes - the incentive push.
Heiler S; Wang Z; Zöller M
World J Gastroenterol; 2016 Jul; 22(26):5971-6007. PubMed ID: 27468191
[TBL] [Abstract][Full Text] [Related]
17. FOLFOX Therapy Induces Feedback Upregulation of CD44v6 through YB-1 to Maintain Stemness in Colon Initiating Cells.
Ghatak S; Hascall VC; Markwald RR; Misra S
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33451103
[TBL] [Abstract][Full Text] [Related]
18. Soluble CD44 standard, CD44 variant 5 and CD44 variant 6 and their relation to staging in head and neck cancer.
Kawano T; Yanoma S; Nakamura Y; Ozeki A; Kokatsu T; Kubota A; Furukawa M; Tsukuda M
Acta Otolaryngol; 2005 Apr; 125(4):392-7. PubMed ID: 15823810
[TBL] [Abstract][Full Text] [Related]
19. CD44 and its v6 spliced variant in lung carcinomas: relation to NCAM, CEA, EMA and UP1 and prognostic significance.
Nguyen VN; Mirejovský T; Melinová L; Mandys V
Neoplasma; 2000; 47(6):400-8. PubMed ID: 11263866
[TBL] [Abstract][Full Text] [Related]
20. Role of CD44s and CD44v6 on human breast cancer cell adhesion, migration, and invasion.
Afify A; Purnell P; Nguyen L
Exp Mol Pathol; 2009 Apr; 86(2):95-100. PubMed ID: 19167378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
